AtheroGenics, Inc.{AGIX}-nasdaq Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kenhott who wrote (176)	1/19/2006 2:19:41 PM
From: tuck	Read Replies (1) of 332

Interesting call; here's some color: finance.messages.yahoo.com This is apparently from analyst Jonathan Aschoff, who a while ago did a bad job of impersonating a doctor to try to get information from a guy who really was doctor. pulitzer.org FBR ultimately fired Aschoff, so I guess Brean Murray is where he landed. Kind of surprised regulators haven't kicked him out of the industry. Further, his mention that AZN isn't funding any of the PIII is a very transparent red herring, since AGIX had funded it before the deal was struck, and spending going forward will be minimal. Only an idiot who did no DD beyond reading this report would fall for that one. His point that the deal is back end loaded is well taken, but that proves nothing, as we both know. AZN still put up $50 million for some reason; could be deep research, could be desperate gambling. Here's a much rosier view from Zack's whose biotech analysts probably aren't much smarter, but probably are more ethical: finance.messages.yahoo.com Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next